It is almost a no-brainer, with digital natives disrupting every industry. The organizations today feel that there is a strong need to reinvent themselves ...
Read more: SciClone Pharma tests hepatitis drug as Covid-19 vaccine enhancer
Friday, April 30, 2021
Pharma Reviews: CII to lend helping hand to govts in Covid fight
CHENNAI: Confederation of Indian Industry (CII) will set up 500 mobile ... CII members in pharma sectors have ramped up production of Remdesivir, ...
Read more: CII to lend helping hand to govts in Covid fight
Read more: CII to lend helping hand to govts in Covid fight
US FDA News: Acella Pharmaceuticals, LLC, Issues Voluntary Nationwide Recall of Certain Lots of NP Thyroid® (Thyroid Tablets, USP) Due to Sub Potency
Acella Pharmaceuticals, LLC, is voluntarily recalling certain lots listed in the Tables 1 and 2 below of 15-mg, 30-mg, 60-mg, 90-mg and 120-mg NP Thyroid®, Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to the consumer level. The products are being recalled because routine testing h
Read more: Acella Pharmaceuticals, LLC, Issues Voluntary Nationwide Recall of Certain Lots of NP Thyroid® (Thyroid Tablets, USP) Due to Sub Potency
Read more: Acella Pharmaceuticals, LLC, Issues Voluntary Nationwide Recall of Certain Lots of NP Thyroid® (Thyroid Tablets, USP) Due to Sub Potency
US FDA News: Coronavirus (COVID-19) Update: April 30, 2021
Coronavirus (COVID-19) Update: April 30, 2021
Read more: Coronavirus (COVID-19) Update: April 30, 2021
Read more: Coronavirus (COVID-19) Update: April 30, 2021
US FDA News: FDA Approves Treatment for Chronic Kidney Disease
Today, the FDA approved a treatment to reduce the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression.
Read more: FDA Approves Treatment for Chronic Kidney Disease
Read more: FDA Approves Treatment for Chronic Kidney Disease
US FDA News: Pacific Medical Group (DBA Avante Health Solutions) Recalls Alaris Infusion Pump Module 8100 Bezel Due to Possible Cracked or Separated Bezel Repair Posts
The Alaris Pump Bezel Assembly from Pacific Medical Group is used to repair and service infusion pump modules. Over time, the bezel repair posts may crack or break.
Read more: Pacific Medical Group (DBA Avante Health Solutions) Recalls Alaris Infusion Pump Module 8100 Bezel Due to Possible Cracked or Separated Bezel Repair Posts
Read more: Pacific Medical Group (DBA Avante Health Solutions) Recalls Alaris Infusion Pump Module 8100 Bezel Due to Possible Cracked or Separated Bezel Repair Posts
US FDA News: FDA Approves Higher Dosage of Naloxone Nasal Spray to Treat Opioid Overdose
FDA approves a higher dose naloxone nasal spray product to treat opioid overdose. The newly approved product delivers 8 milligrams (mg) of naloxone into the nasal cavity.
Read more: FDA Approves Higher Dosage of Naloxone Nasal Spray to Treat Opioid Overdose
Read more: FDA Approves Higher Dosage of Naloxone Nasal Spray to Treat Opioid Overdose
Pharma Reviews: COVID Pandemic Has Disrupted Global Value Chains, India Must Reorient Its Trade Policy
Investment in IT and digital infrastructure positively impacts exports diversification, as seen in the case of the Indian pharmaceutical industry.
Read more: COVID Pandemic Has Disrupted Global Value Chains, India Must Reorient Its Trade Policy
Read more: COVID Pandemic Has Disrupted Global Value Chains, India Must Reorient Its Trade Policy
Pharma Reviews: Relaxing the Covaxin Patent is in the Interest of Bharat Biotech as well as Bharat
India needs to lead by example and relax the patent for Covaxin, the ... of Bharat Biotech and begin the transformation of the Indian pharma sector ...
Read more: Relaxing the Covaxin Patent is in the Interest of Bharat Biotech as well as Bharat
Read more: Relaxing the Covaxin Patent is in the Interest of Bharat Biotech as well as Bharat
Pharma Reviews: India Healthcare services heal across borders and SEIS is the need of the hour
Today, the country is a major medical tourism destination for patients mainly from Africa, ... India's healthcare sector has approximately grown to $100 billion in size by 2015, ... The industry was expected to touch $280 billion by 2020.
Read more: India Healthcare services heal across borders and SEIS is the need of the hour
Read more: India Healthcare services heal across borders and SEIS is the need of the hour
Pharma Reviews: Stock Market Live Updates: Sensex falls 500 points, Nifty below 14800 dragged by financials, FMCG
Stock Market Live Updates: The Indian equity indices, Sensex and Nifty ... Among sectors, metal, IT and pharma indices traded higher, while selling ...
Read more: Stock Market Live Updates: Sensex falls 500 points, Nifty below 14800 dragged by financials, FMCG
Read more: Stock Market Live Updates: Sensex falls 500 points, Nifty below 14800 dragged by financials, FMCG
Thursday, April 29, 2021
Pharma Reviews: Almost every exponential technology is starting to find its way in improving our approach to markets ...
It is almost a no-brainer, with digital natives disrupting every industry. ... Pharmaceutical industry traditionally has not been at the forefront of digital ...
Read more: Almost every exponential technology is starting to find its way in improving our approach to markets ...
Read more: Almost every exponential technology is starting to find its way in improving our approach to markets ...
Pharma Reviews: Coronavirus Crisis LIVE: First flight carrying COVID-19 relief supplies from the US lands in Delhi
He has also been holding meetings with pharma industry leaders, oxygen ... #COVID19 relief shipments from the United States has arrived in India!
Read more: Coronavirus Crisis LIVE: First flight carrying COVID-19 relief supplies from the US lands in Delhi
Read more: Coronavirus Crisis LIVE: First flight carrying COVID-19 relief supplies from the US lands in Delhi
Pharma Reviews: Pharmexcil seeks Indian Ambassador in China's help on Sichuan Airline issue
Uday Bhaskar, Director General of Pharmaceuticals Export Promotion Council of India (Pharmexcil), in a letter written to Misri, stated that the cargo ...
Read more: Pharmexcil seeks Indian Ambassador in China's help on Sichuan Airline issue
Read more: Pharmexcil seeks Indian Ambassador in China's help on Sichuan Airline issue
Pharma Reviews: Biden can't see Indo-Pacific and pandemic with two prisms. Covid is the new reality
Whatever be the reason for the delay in releasing the supply of raw materials for India's pharmaceutical industry, the US has not covered itself in glory.
Read more: Biden can't see Indo-Pacific and pandemic with two prisms. Covid is the new reality
Read more: Biden can't see Indo-Pacific and pandemic with two prisms. Covid is the new reality
Pharma Reviews: Pressure Mounts On US Pharma Giants To Share Vaccine Technology As World Losing Out To ...
... a proposal to temporarily waive patents given to big US pharma companies ... Influential Indian-American groups are backing the move to waive the ...
Read more: Pressure Mounts On US Pharma Giants To Share Vaccine Technology As World Losing Out To ...
Read more: Pressure Mounts On US Pharma Giants To Share Vaccine Technology As World Losing Out To ...
Pharma Reviews: India-US partnership has deepened during COVID-19 pandemic: IMC Chamber
Case in point, Indian pharmaceutical companies supplied over 40 percent of generic demand in the United States in recent years. "The US is a huge ...
Read more: India-US partnership has deepened during COVID-19 pandemic: IMC Chamber
Read more: India-US partnership has deepened during COVID-19 pandemic: IMC Chamber
Pharma Reviews: Pharma exports body seeks Indian Ambassador in China s intervention on Sichuan Airline issue
Director General of Pharmaceuticals Export Promotion Council of India (Pharmexcil), Udaya Bhaskar, in a letter written to Misri stated that the cargo ...
Read more: Pharma exports body seeks Indian Ambassador in China s intervention on Sichuan Airline issue
Read more: Pharma exports body seeks Indian Ambassador in China s intervention on Sichuan Airline issue
US FDA News: FDA Commits to Evidence-Based Actions Aimed at Saving Lives and Preventing Future Generations of Smokers
FDA commits to advancing two tobacco product standards to significantly reduce disease and death from using combusted tobacco products, the leading cause of preventable death in the U.S.
Read more: FDA Commits to Evidence-Based Actions Aimed at Saving Lives and Preventing Future Generations of Smokers
Read more: FDA Commits to Evidence-Based Actions Aimed at Saving Lives and Preventing Future Generations of Smokers
Wednesday, April 28, 2021
Pharma Reviews: Why '98% of oximeters in Indian market are Made-in-China' but buyers don't care
This translates to nearly a quarter of India's total medical equipment imports for the period. Industry insiders in the pulse oximeter market cite ...
Read more: Why '98% of oximeters in Indian market are Made-in-China' but buyers don't care
Read more: Why '98% of oximeters in Indian market are Made-in-China' but buyers don't care
Pharma Reviews: Is India 'Hesitating' to Get Remdesivir From Bangladesh? Why?
Clones of Remdesivir in Bangladesh Market. Bangladesh has been very protective of its domestic pharma market. It has a mature pharma industry and ...
Read more: Is India 'Hesitating' to Get Remdesivir From Bangladesh? Why?
Read more: Is India 'Hesitating' to Get Remdesivir From Bangladesh? Why?
Pharma Reviews: Patents can't impede pandemic response
It must be remembered that India moved from product patenting to process patenting in 1972. That gave the Indian pharmaceutical industry a huge ...
Read more: Patents can't impede pandemic response
Read more: Patents can't impede pandemic response
Pharma Reviews: Partnering with Pharma to Transform Drug Delivery
Express Pharma, first published as Express Pharma Pulse in 1994, is today India's leading business fortnightly for the pharmaceutical industry.
Read more: Partnering with Pharma to Transform Drug Delivery
Read more: Partnering with Pharma to Transform Drug Delivery
Pharma Reviews: Android Biomed- Bringing Change in Cosmetology
Both have been in the pharma industry for over 15 years now. ... India's best Glutathione brand, Adroit has an almost monopoly in the market for the ...
Read more: Android Biomed- Bringing Change in Cosmetology
Read more: Android Biomed- Bringing Change in Cosmetology
US FDA News: Scentsational Soaps & Candles, Inc. Issues Voluntary Nationwide Recall of Scented Hand Sanitizers Due to the Presence of Methanol (Wood Alcohol), Benzene and Acetaldehyde
Scentsational Soaps & Candles, Inc., is voluntarily recalling 5 lots of Scentsational Soaps & Candles scented Hand Sanitizers from the Black and White Collection and Photo Real Collection and 3 lots of Ulta Beauty Collection scented Hand Sanitizer Spray packaged in 3.38 and 3.4 fluid ounce spray bot
Read more: Scentsational Soaps & Candles, Inc. Issues Voluntary Nationwide Recall of Scented Hand Sanitizers Due to the Presence of Methanol (Wood Alcohol), Benzene and Acetaldehyde
Read more: Scentsational Soaps & Candles, Inc. Issues Voluntary Nationwide Recall of Scented Hand Sanitizers Due to the Presence of Methanol (Wood Alcohol), Benzene and Acetaldehyde
Pharma Reviews: Merck inks licensing pact with Cipla, Sun Pharma, 3 others for oral COVID drug Molnupiravir
... has entered into a voluntary licensing agreement with five Indian generics manufacturers including Cipla Limited, Dr Reddy's Laboratories Limited, ...
Read more: Merck inks licensing pact with Cipla, Sun Pharma, 3 others for oral COVID drug Molnupiravir
Read more: Merck inks licensing pact with Cipla, Sun Pharma, 3 others for oral COVID drug Molnupiravir
US FDA News: FDA Takes Action For Failure to Submit Required Clinical Trial Results Information to ClinicalTrials.Gov
FDA Issued a Notice of Noncompliance For Failure to Submit Required Clinical Trial Results Information to ClinicalTrials.Gov
Read more: FDA Takes Action For Failure to Submit Required Clinical Trial Results Information to ClinicalTrials.Gov
Read more: FDA Takes Action For Failure to Submit Required Clinical Trial Results Information to ClinicalTrials.Gov
Pharma Reviews: Go for economy facing stocks but don't exit pharma: Andrew Holland
The market or investors tried to look through the number of cases and decided to focus on vaccinations. That is going to be the case in India too.
Read more: Go for economy facing stocks but don't exit pharma: Andrew Holland
Read more: Go for economy facing stocks but don't exit pharma: Andrew Holland
Pharma Reviews: Morepen Labs to expand POC Dx business
The balance $67.50 million would be in the promoter group companies. ... Corinth Capital Fund said,“We are bullish about the Indian market and have already ... In the domestic market Morepen is a leader in the point of care medical ...
Read more: Morepen Labs to expand POC Dx business
Read more: Morepen Labs to expand POC Dx business
Pharma Reviews: Chinese media claims western clients seeking pharma goods turning away from India
As the COVID-19 crisis continues in India, there are questions about the normal functioning of the pharmaceutical industry in the country. India is the ...
Read more: Chinese media claims western clients seeking pharma goods turning away from India
Read more: Chinese media claims western clients seeking pharma goods turning away from India
Tuesday, April 27, 2021
Pharma Reviews: Pandemic or Not, Health is Playing a Key Role in Foreign Policy and India is Taking the Lead
India's health diplomacy efforts are also supported by a robust pharma sector. Indian pharma currently contributes around 20 percent of the worlds' ...
Read more: Pandemic or Not, Health is Playing a Key Role in Foreign Policy and India is Taking the Lead
Read more: Pandemic or Not, Health is Playing a Key Role in Foreign Policy and India is Taking the Lead
Pharma Reviews: MSD Pharma signs pact with 5 Indian firms to make investigational covid-19 drug
MSD Pharmaceuticals Pvt Ltd, a wholly-owned subsidiary of Merck Sharp & Dohme (MSD), on Tuesday announced it has signed non-exclusive ...
Read more: MSD Pharma signs pact with 5 Indian firms to make investigational covid-19 drug
Read more: MSD Pharma signs pact with 5 Indian firms to make investigational covid-19 drug
Pharma Reviews: COVID-19 surge and diplomacy of vaccine
At the current rate of 2.2mn doses per day, India can only cover 30% population by the end-2021.India's Pharma Industry is being flooded with deals ...
Read more: COVID-19 surge and diplomacy of vaccine
Read more: COVID-19 surge and diplomacy of vaccine
US FDA News: Coronavirus (COVID-19) Update: April 27, 2021
Coronavirus (COVID-19) Update: April 27, 2021
Read more: Coronavirus (COVID-19) Update: April 27, 2021
Read more: Coronavirus (COVID-19) Update: April 27, 2021
Pharma Reviews: How Technological Innovations will Affect the Pharmacy Supply Chain
Today, the Indian healthcare sector is poised at a very interesting stage. As the acknowledged pharmacy of the world, our aim has been to become a ...
Read more: How Technological Innovations will Affect the Pharmacy Supply Chain
Read more: How Technological Innovations will Affect the Pharmacy Supply Chain
Pharma Reviews: Understanding the role of health in foreign policy: The Indian experience
Indian pharma currently contributes around 20 percent of the worlds' generics ... India's public health sector along with its pharmaceutical industry has ...
Read more: Understanding the role of health in foreign policy: The Indian experience
Read more: Understanding the role of health in foreign policy: The Indian experience
Pharma Reviews: MSD to sign licensing pacts with 5 Indian drug firms for oral drug candidate for COVID-19
Drug firm MSD has decided to enter into voluntary licensing agreements for investigational oral antiviral drug candidate 'molnupiravir', which is being ...
Read more: MSD to sign licensing pacts with 5 Indian drug firms for oral drug candidate for COVID-19
Read more: MSD to sign licensing pacts with 5 Indian drug firms for oral drug candidate for COVID-19
Pharma Reviews: Employer branding: Emerging trends in the COVID era
Leveraging employees to become the company's spokespeople is an ... “The Indian pharmaceuticals industry is very fragmented, with small and ...
Read more: Employer branding: Emerging trends in the COVID era
Read more: Employer branding: Emerging trends in the COVID era
Pharma Reviews: Max Bupa's HR digitalization journey to becoming a great place to work
“The Indian pharmaceuticals industry is very fragmented, with small and medium enterprises (SMEs) accounting for 35-40 per cent of production in value ...
Read more: Max Bupa's HR digitalization journey to becoming a great place to work
Read more: Max Bupa's HR digitalization journey to becoming a great place to work
Pharma Reviews: Versatility in the learning environment is critical: Head L&D, AirAsia India
She has worked across multiple industries including BFSI, auto, manufacturing, FMCG, hospitality, pharma, and IT/ITES. In this exclusive interaction with ...
Read more: Versatility in the learning environment is critical: Head L&D, AirAsia India
Read more: Versatility in the learning environment is critical: Head L&D, AirAsia India
Monday, April 26, 2021
Pharma Reviews: Emergence of a digital ecosystem for the pharma industry
A significant chunk of this sector comprises small and medium enterprises (SMEs). “The Indian pharmaceuticals industry is very fragmented, with small ...
Read more: Emergence of a digital ecosystem for the pharma industry
Read more: Emergence of a digital ecosystem for the pharma industry
Pharma Reviews: USA lifts bans on raw materials for vaccine amid criticism
The Indian vaccine manufacturers such as SII and Biological E require raw ... between both companies into countries during the pandemic ravaging in India. ... the world from health crisis while big pharma companies kept crying foul.
Read more: USA lifts bans on raw materials for vaccine amid criticism
Read more: USA lifts bans on raw materials for vaccine amid criticism
Pharma Reviews: Optimus Pharma launched a new Anti-Parkinson's Drug in India
Hyderabad (Telangana) [India], April 26 (ANI/PNN): Optimus Pharma has ... the absence of disease-modifying therapies, especially in Indian Market.
Read more: Optimus Pharma launched a new Anti-Parkinson's Drug in India
Read more: Optimus Pharma launched a new Anti-Parkinson's Drug in India
Pharma Reviews: Future-ready supply chains
As Sudarshan Jain, Secretary-General, Indian Pharmaceutical Alliance reminds, “The COVID-19 pandemic has put the pharma industry on a ...
Read more: Future-ready supply chains
Read more: Future-ready supply chains
Pharma Reviews: Banks & financials lift Sensex 508 pts; Nifty ends 1% higher; HCL Tech top drag
“Indian markets made an optimistic start tracking firm global cues. Investors reacted to ... Nifty Pharma under pressure dragged by Cipla. Pharma cos.
Read more: Banks & financials lift Sensex 508 pts; Nifty ends 1% higher; HCL Tech top drag
Read more: Banks & financials lift Sensex 508 pts; Nifty ends 1% higher; HCL Tech top drag
Sunday, April 25, 2021
Pharma Reviews: Unpacking the India-EU economic relationship
The EU expects India to strengthen its IPR regime, which may have a critical impact on India's vast pharmaceutical and generic drug sector. India and ...
Read more: Unpacking the India-EU economic relationship
Read more: Unpacking the India-EU economic relationship
Pharma Reviews: Covid-19: Second wave has shaken country, says PM Modi
... efforts to contain the spread of infections, Modi said he has had lengthy deliberations with experts from the pharma industry, vaccine manufacturers, ...
Read more: Covid-19: Second wave has shaken country, says PM Modi
Read more: Covid-19: Second wave has shaken country, says PM Modi
Pharma Reviews: J&J seeks permission for phase-3 trial of its single-shot Covid vaccine in India, import licence
NEW DELHI: Multinational pharma giant Johnson & Johnson has applied to India's ... They said the company has sought an early meeting of the subject expert ... Laboratories - has also been approved by the Indian drug regulator.
Read more: J&J seeks permission for phase-3 trial of its single-shot Covid vaccine in India, import licence
Read more: J&J seeks permission for phase-3 trial of its single-shot Covid vaccine in India, import licence
Pharma Reviews: Apex Laboratories gets approval for CleVira as Covid supportive drug
The company said this is the first of its kind approval in India through various stages of scrutiny at The Central Council for Research in Ayurvedic ...
Read more: Apex Laboratories gets approval for CleVira as Covid supportive drug
Read more: Apex Laboratories gets approval for CleVira as Covid supportive drug
Pharma Reviews: Telangana pharma can take on world
Reducing the Indian manufacturing industries' dependence on imports will be another ... Production-linked incentives will boost the pharma industry.
Read more: Telangana pharma can take on world
Read more: Telangana pharma can take on world
Pharma Reviews: SII breaks silence, calls Covishield most affordable jab
The Indian biotechnology and pharmaceuticals company announced the new prices after the government allowed vaccination for all persons above ...
Read more: SII breaks silence, calls Covishield most affordable jab
Read more: SII breaks silence, calls Covishield most affordable jab
Pharma Reviews: Indian Pharma Market sees significant revival in March 2021, registers 10.3 percent growth: AIOCD ...
New Delhi: The Indian Pharmaceutical Market (IPM) has witnessed a significant revival with a rise of 10.3 per cent for the month of March 2021, ...
Read more: Indian Pharma Market sees significant revival in March 2021, registers 10.3 percent growth: AIOCD ...
Read more: Indian Pharma Market sees significant revival in March 2021, registers 10.3 percent growth: AIOCD ...
Saturday, April 24, 2021
Pharma Reviews: Amid India's request to lift ban, US defends restrictions on export of Covid vaccine raw materials
The Biden administration recently conveyed to New Delhi that it understands India's pharmaceutical requirements and promised to give the matter due ...
Read more: Amid India's request to lift ban, US defends restrictions on export of Covid vaccine raw materials
Read more: Amid India's request to lift ban, US defends restrictions on export of Covid vaccine raw materials
Pharma Reviews: Chinese loan apps pose a threat to India
Further, the Indian pharma industry has also seen an increase in Chinese FDI. As mentioned in the previous section, India's technology sector has ...
Read more: Chinese loan apps pose a threat to India
Read more: Chinese loan apps pose a threat to India
Friday, April 23, 2021
Pharma Reviews: US may not rush inputs for vaccines, Germany rethinks pharma sector aid
NEW DELHI: As India's Covid crisis deepens, US rejected a key demand by Indian vaccine makers, indicating it would prioritise its own citizens before ...
Read more: US may not rush inputs for vaccines, Germany rethinks pharma sector aid
Read more: US may not rush inputs for vaccines, Germany rethinks pharma sector aid
Pharma Reviews: To plea on lifting ban on vaccine inputs, US says Americans first
Days after Serum Institute of India CEO Adar Poonawalla urged US ... the last few weeks to address supply chain issues faced by our pharma industry.
Read more: To plea on lifting ban on vaccine inputs, US says Americans first
Read more: To plea on lifting ban on vaccine inputs, US says Americans first
Pharma Reviews: Opium cultivation in private sector: A welcome partnership
Codeine phosphate has the largest demand-in fact the production in the Indian factories is insufficient to meet the demands of the pharma industry.
Read more: Opium cultivation in private sector: A welcome partnership
Read more: Opium cultivation in private sector: A welcome partnership
US FDA News: FDA and CDC Lift Recommended Pause on Johnson & Johnson (Janssen) COVID-19 Vaccine Use Following Thorough Safety Review
Following a thorough safety review, the U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention have determined that the recommended pause regarding the use of the Johnson & Johnson (Janssen) COVID-19 Vaccine in the U.S. should be lifted.
Read more: FDA and CDC Lift Recommended Pause on Johnson & Johnson (Janssen) COVID-19 Vaccine Use Following Thorough Safety Review
Read more: FDA and CDC Lift Recommended Pause on Johnson & Johnson (Janssen) COVID-19 Vaccine Use Following Thorough Safety Review
Pharma Reviews: While Govt has got the PLI scheme right, it must address the criticism about protectionism on the ...
The way to realise the aim of becoming a $5tn Indian economy (currently ... In the pharma sector, 130 companies have submitted expressions of ...
Read more: While Govt has got the PLI scheme right, it must address the criticism about protectionism on the ...
Read more: While Govt has got the PLI scheme right, it must address the criticism about protectionism on the ...
Pharma Reviews: 'Americans first': US cites domestic priorities to reject India's vaccine plea
Meanwhile, German chancellor Angela Merkel expressed doubts about helping India develop its pharma sector, especially as India has tightened its ...
Read more: 'Americans first': US cites domestic priorities to reject India's vaccine plea
Read more: 'Americans first': US cites domestic priorities to reject India's vaccine plea
US FDA News: Coronavirus (COVID-19) Update: April 23, 2021
Coronavirus (COVID-19) Update: April 23, 2021
Read more: Coronavirus (COVID-19) Update: April 23, 2021
Read more: Coronavirus (COVID-19) Update: April 23, 2021
Pharma Reviews: Govt holds discussions with Covid vaccine makers, senior officials to ensure vaccine availability
NEW DELHI: Indian foriegn minister S Jaishankar held discussions with ... few weeks to address supply chain issues faced by our pharma industry.
Read more: Govt holds discussions with Covid vaccine makers, senior officials to ensure vaccine availability
Read more: Govt holds discussions with Covid vaccine makers, senior officials to ensure vaccine availability
US FDA News: Cordis Recalls Precise PRO Rx US Carotid System Due to Risk of Separation in Device During Use
The Precise PRO Rx US Carotid System is used in patients with narrowing carotid arteries. There is a recall due to risk of separation at a specific point.
Read more: Cordis Recalls Precise PRO Rx US Carotid System Due to Risk of Separation in Device During Use
Read more: Cordis Recalls Precise PRO Rx US Carotid System Due to Risk of Separation in Device During Use
US FDA News: FDA Authorizes Marketing of Device to Facilitate Muscle Rehabilitation in Stroke Patients
The U.S. Food and Drug Administration has authorized marketing of a new device indicated for use in patients 18 and older undergoing stroke rehabilitation, to facilitate muscle re-education and for maintaining or increasing range of motion.
Read more: FDA Authorizes Marketing of Device to Facilitate Muscle Rehabilitation in Stroke Patients
Read more: FDA Authorizes Marketing of Device to Facilitate Muscle Rehabilitation in Stroke Patients
Pharma Reviews: Merck working closely with leading Indian Pharma giant to develop pill that can eliminate coronavirus
It could hit the market within 4 to 5 months. What's needed to expedite the introduction of this drug in India currently is emergency use authorisation by ...
Read more: Merck working closely with leading Indian Pharma giant to develop pill that can eliminate coronavirus
Read more: Merck working closely with leading Indian Pharma giant to develop pill that can eliminate coronavirus
Pharma Reviews: Digitisation, collaboration will help pharma companies succeed in the “next normal”: Experts
The Indian pharmaceutical industry underwent a paradigm shift in the year 2020. Due to the COVID-19 pandemic, the sector adopted several practices ...
Read more: Digitisation, collaboration will help pharma companies succeed in the “next normal”: Experts
Read more: Digitisation, collaboration will help pharma companies succeed in the “next normal”: Experts
Pharma Reviews: Angela Merkel laments that they 'allowed' India to become pharmacy of the world, fears that they ...
But it was blocked by the developed nations, which are home to major global pharmaceutical companies. They argued that it will stifle innovation at ...
Read more: Angela Merkel laments that they 'allowed' India to become pharmacy of the world, fears that they ...
Read more: Angela Merkel laments that they 'allowed' India to become pharmacy of the world, fears that they ...
Pharma Reviews: Stock Market Live Updates: Sensex in the red, Nifty below 14400 amid volatility; Phamra, FMCG ...
Stock Market Live Updates: Indian indices, Sensex and Nifty traded lower Friday afternoon dragged by selling in FMCG and pharma stocks.
Read more: Stock Market Live Updates: Sensex in the red, Nifty below 14400 amid volatility; Phamra, FMCG ...
Read more: Stock Market Live Updates: Sensex in the red, Nifty below 14400 amid volatility; Phamra, FMCG ...
Thursday, April 22, 2021
Pharma Reviews: Explained: Can states block oxygen supply? Why surplus producer India faces crisis?
Most oxygen manufactured in India is consumed by the industry. In pre-Covid-19 times, India had a demand of 700 tonne per day (TPD) of liquid medical ...
Read more: Explained: Can states block oxygen supply? Why surplus producer India faces crisis?
Read more: Explained: Can states block oxygen supply? Why surplus producer India faces crisis?
US FDA News: FDA Approves Immunotherapy for Endometrial Cancer with Specific Biomarker
Today, the FDA approved an immunotherapy for endometrial cancers that have a specific genetic feature known as dMMR which contain abnormalities that affect the proper repair of DNA inside the cell.
Read more: FDA Approves Immunotherapy for Endometrial Cancer with Specific Biomarker
Read more: FDA Approves Immunotherapy for Endometrial Cancer with Specific Biomarker
Pharma Reviews: Pharma stocks scale fresh highs amid record rise in Covid-19 cases
Apollo Hospitals share price also hit a fresh 52 week high in today's session. Many brokerages believe the Indian pharmaceutical sector is set for a ...
Read more: Pharma stocks scale fresh highs amid record rise in Covid-19 cases
Read more: Pharma stocks scale fresh highs amid record rise in Covid-19 cases
Pharma Reviews: Stock Market Live Updates: Sensex gains over 200 points, Nifty above 14350; banks, metals shine ...
Gland Pharma has begun the production of Remdesivir for the Indian market a couple of weeks ago, according to people in the know. Currently, they are ...
Read more: Stock Market Live Updates: Sensex gains over 200 points, Nifty above 14350; banks, metals shine ...
Read more: Stock Market Live Updates: Sensex gains over 200 points, Nifty above 14350; banks, metals shine ...
Pharma Reviews: Jubilant Pharmova arm completes studies using novel oral formulation of Remdesivir
In a relief to Covid patients, pharmaceutical companies manufacturing Remdesivir in India have significantly lowered prices of the drug being given to ...
Read more: Jubilant Pharmova arm completes studies using novel oral formulation of Remdesivir
Read more: Jubilant Pharmova arm completes studies using novel oral formulation of Remdesivir
Pharma Reviews: Market LIVE Updates: Indices trade higher led by metal, financials; FMCG drags
Medical oxygen producing companies shares are trading higher amid ... taken out Rs 4,852 crore from the Indian financial market this month so far.
Read more: Market LIVE Updates: Indices trade higher led by metal, financials; FMCG drags
Read more: Market LIVE Updates: Indices trade higher led by metal, financials; FMCG drags
Pharma Reviews: Bharat Biotech's Covaxin demonstrates 100% efficacy against severe Covid-19 disease in Phase 3 ...
Hyderabad-based vaccine manufacturer Bharat Biotech announced second ... “I am very pleased to state that Covaxin, the first indigenous Covid-19 ... of Health Research & Director General at Indian Council of Medical Research.
Read more: Bharat Biotech's Covaxin demonstrates 100% efficacy against severe Covid-19 disease in Phase 3 ...
Read more: Bharat Biotech's Covaxin demonstrates 100% efficacy against severe Covid-19 disease in Phase 3 ...
Wednesday, April 21, 2021
Pharma Reviews: Take a jab! 12 healthcare stocks hit fresh 52-week high; huge opportunity for long term investors?
India's pharmaceutical industry stood strong in times when the COVID-19 pandemic has pushed several economies and businesses to the brink.”.
Read more: Take a jab! 12 healthcare stocks hit fresh 52-week high; huge opportunity for long term investors?
Read more: Take a jab! 12 healthcare stocks hit fresh 52-week high; huge opportunity for long term investors?
Pharma Reviews: Pollutants found in pharma giant's monitoring wells
On the impact of industrial effluent on the quality of surface water and sediments of nearby waterbodies , the committee has given a clean chit to Sun ...
Read more: Pollutants found in pharma giant's monitoring wells
Read more: Pollutants found in pharma giant's monitoring wells
Pharma Reviews: 89 percent of all prescriptions dispensed with a generic drug – Generics True need of the hour
Today, India is at a prominent position with a rapidly growing presence in global pharmaceuticals. It is the largest provider of generic medicines ...
Read more: 89 percent of all prescriptions dispensed with a generic drug – Generics True need of the hour
Read more: 89 percent of all prescriptions dispensed with a generic drug – Generics True need of the hour
US FDA News: FDA Continues Important Steps to Ensure Quality, Safety and Effectiveness of Authorized COVID-19 Vaccines
FDA Continues Important Steps to Ensure Quality, Safety and Effectiveness of Authorized COVID-19 Vaccines
Read more: FDA Continues Important Steps to Ensure Quality, Safety and Effectiveness of Authorized COVID-19 Vaccines
Read more: FDA Continues Important Steps to Ensure Quality, Safety and Effectiveness of Authorized COVID-19 Vaccines
Pharma Reviews: Biden admin acknowledges India's urgent pharma requirements; blames Act that prioritises ...
Washington: The Biden administration has conveyed to New Delhi that it understands India's pharmaceutical requirements and promised to give the ...
Read more: Biden admin acknowledges India's urgent pharma requirements; blames Act that prioritises ...
Read more: Biden admin acknowledges India's urgent pharma requirements; blames Act that prioritises ...
Pharma Reviews: Pharma firms with approval for projects under PLI scheme should start production at the earliest ...
This will enable India to provide pharma and medical devices products to domestic and global markets at competitive rates. Latest UpdatesMarket · By ...
Read more: Pharma firms with approval for projects under PLI scheme should start production at the earliest ...
Read more: Pharma firms with approval for projects under PLI scheme should start production at the earliest ...
Tuesday, April 20, 2021
Pharma Reviews: PLI scheme: Gowda asks pharma, medical devices cos to begin production at earliest
Terming India as a major hub for medical devices and diagnostics, ... Gowda noted that pharma and medical device sectors could play a pivotal role in ...
Read more: PLI scheme: Gowda asks pharma, medical devices cos to begin production at earliest
Read more: PLI scheme: Gowda asks pharma, medical devices cos to begin production at earliest
Pharma Reviews: Govt approves ramping up remdesivir production to around 78 lakh vials per month
As an additional measure, remdesivir, active pharmaceutical ingredient ... by Drugs Controller General of India (DCGI) to take immediate action on ...
Read more: Govt approves ramping up remdesivir production to around 78 lakh vials per month
Read more: Govt approves ramping up remdesivir production to around 78 lakh vials per month
Pharma Reviews: Blood clots should be listed as rare Johnson & Johnson side effect, says Europe drug watchdog
7 pharma cos slash Remdesivir price. In a relief to Covid patients, pharmaceutical companies manufacturing Remdesivir in India have significantly ...
Read more: Blood clots should be listed as rare Johnson & Johnson side effect, says Europe drug watchdog
Read more: Blood clots should be listed as rare Johnson & Johnson side effect, says Europe drug watchdog
Pharma Reviews: Modi to meet vaccine manufacturers today
Representatives of top drug makers from India and abroad, including companies whose vaccines have been approved by the government will attend the ...
Read more: Modi to meet vaccine manufacturers today
Read more: Modi to meet vaccine manufacturers today
US FDA News: BD Announces the Voluntary Recall of Specified Lots of ChloraPrep™ Hi-Lite Orange™ 26 mL Applicator in the United States and U.S. Territories Due to Defective Applicator
BD (Becton, Dickinson and Company), a leading global medical technology company, is voluntarily recalling specified lots of the ChloraPrep™ Hi-Lite Orange™ 26 mL Applicator (2% w/w chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA)) to the user level due to a defective applicator.
Read more: BD Announces the Voluntary Recall of Specified Lots of ChloraPrep™ Hi-Lite Orange™ 26 mL Applicator in the United States and U.S. Territories Due to Defective Applicator
Read more: BD Announces the Voluntary Recall of Specified Lots of ChloraPrep™ Hi-Lite Orange™ 26 mL Applicator in the United States and U.S. Territories Due to Defective Applicator
US FDA News: Coronavirus (COVID-19) Update: April 20, 2021
Coronavirus (COVID-19) Update: April 20, 2021
Read more: Coronavirus (COVID-19) Update: April 20, 2021
Read more: Coronavirus (COVID-19) Update: April 20, 2021
Pharma Reviews: Covid Updates: As more states opt for lockdown-like restrictions, PM says lockdown should be the ...
India gets elected to 3 UN Economic and Social Council bodies - ... Pharma sector working relentlessly to meet all COVID-19 challenges, including on ...
Read more: Covid Updates: As more states opt for lockdown-like restrictions, PM says lockdown should be the ...
Read more: Covid Updates: As more states opt for lockdown-like restrictions, PM says lockdown should be the ...
Pharma Reviews: India's Trade Performance resilient during 2020-21; Cumulative value of overall exports ...
India's dominance in the pharma sector has been reinforced with supply of critical covid related supplies to over 150 countries and rapid growth in ...
Read more: India's Trade Performance resilient during 2020-21; Cumulative value of overall exports ...
Read more: India's Trade Performance resilient during 2020-21; Cumulative value of overall exports ...
Pharma Reviews: Pharma company director denies stocking Remdesivir vials in Mumbai
According to medical doctors treating Covid-19 patients in India, the drug does help in reducing the viral replication however, they highlight that ...
Read more: Pharma company director denies stocking Remdesivir vials in Mumbai
Read more: Pharma company director denies stocking Remdesivir vials in Mumbai
Pharma Reviews: Narendra Modi speech live updates: We should avoid imposing lockdown, it should be our last ...
India now has more than 2 million (20 lakh) officially recorded active cases of ... The pharma sector has already pumped up production of medicines.
Read more: Narendra Modi speech live updates: We should avoid imposing lockdown, it should be our last ...
Read more: Narendra Modi speech live updates: We should avoid imposing lockdown, it should be our last ...
US FDA News: FDA Announces New Streamlined Approach to Add Pooled Serial Screening Claims to Certain Authorized Tests for Use in Serial Testing Programs
FDA announces streamlined EUA amendment for certain molecular test developers to pool specimens as part of a serial testing program.
Read more: FDA Announces New Streamlined Approach to Add Pooled Serial Screening Claims to Certain Authorized Tests for Use in Serial Testing Programs
Read more: FDA Announces New Streamlined Approach to Add Pooled Serial Screening Claims to Certain Authorized Tests for Use in Serial Testing Programs
Pharma Reviews: Union Minister for Chemicals and Fertilizers addresses the Workshop on PLI Scheme for Bulk Drug ...
Addressing the workshop Shri Gowda said that Pharmaceutical and ... He said the onset of COVID-19 has brought the world's attention to India and ...
Read more: Union Minister for Chemicals and Fertilizers addresses the Workshop on PLI Scheme for Bulk Drug ...
Read more: Union Minister for Chemicals and Fertilizers addresses the Workshop on PLI Scheme for Bulk Drug ...
US FDA News: Medtronic Perfusion Systems Recalls Bio-Console 560 Extracorporeal Blood Pumping Console for Possible Electrical Failure Causing the Pump to Stop
The Bio-Console 560 controls a blood pump during cardiopulmonary bypass or ECMO. An electrical failure in the console may cause the pump to stop.
Read more: Medtronic Perfusion Systems Recalls Bio-Console 560 Extracorporeal Blood Pumping Console for Possible Electrical Failure Causing the Pump to Stop
Read more: Medtronic Perfusion Systems Recalls Bio-Console 560 Extracorporeal Blood Pumping Console for Possible Electrical Failure Causing the Pump to Stop
Pharma Reviews: Remdesivir for COVID: This Freedom Fighter & His Son Built Cipla Into What It Is Today
KA Hamied set up Cipla to make India “self-reliant in healthcare”, pioneered in API (Active Pharmaceutical Ingredient) manufacturing and played a ...
Read more: Remdesivir for COVID: This Freedom Fighter & His Son Built Cipla Into What It Is Today
Read more: Remdesivir for COVID: This Freedom Fighter & His Son Built Cipla Into What It Is Today
Pharma Reviews: PLI scheme to improve affordability and accessibility of pharma products: Gowda
Addressing the workshop Shri Gowda said that Pharmaceutical and ... the industry, and meet our goal of bringing Indian Pharmaceuticals and Medical ...
Read more: PLI scheme to improve affordability and accessibility of pharma products: Gowda
Read more: PLI scheme to improve affordability and accessibility of pharma products: Gowda
Pharma Reviews: Bharat Biotech ramps up Covaxin production capacity to 700 mn doses per annum
To support vaccination campaigns in India and across the globe, Bharat ... "The company is able to expand COVAXIN manufacturing capacity in a short ... said it has partnered with Indian Immunologicals (IIL) to manufacture the drug ...
Read more: Bharat Biotech ramps up Covaxin production capacity to 700 mn doses per annum
Read more: Bharat Biotech ramps up Covaxin production capacity to 700 mn doses per annum
Pharma Reviews: Covid-19: How the second wave threatens to nip India's economic recovery in the bud
We look at how four key sectors — auto, pharmaceuticals, consumer durables and aviation — are faring as the country records over 250,000 cases a ...
Read more: Covid-19: How the second wave threatens to nip India's economic recovery in the bud
Read more: Covid-19: How the second wave threatens to nip India's economic recovery in the bud
Pharma Reviews: Stock Market Highlights: Sensex falls 243 points, Nifty ends below 14300 dragged by IT stocks ...
Stock Market Highlights: Indian equity indices, Sensex and Nifty ended Tuesday's volatile ... Gains were seen in pharma, auto and metals stocks.
Read more: Stock Market Highlights: Sensex falls 243 points, Nifty ends below 14300 dragged by IT stocks ...
Read more: Stock Market Highlights: Sensex falls 243 points, Nifty ends below 14300 dragged by IT stocks ...
Pharma Reviews: Market LIVE Updates: Sensex, Nifty flat; pharma, auto, realty gain
Market LIVE Updates: Sensex, Nifty flat; pharma, auto, realty gain. Stock Market Today: Indian indices were in green on Tuesday. (HT) Premium Stock ...
Read more: Market LIVE Updates: Sensex, Nifty flat; pharma, auto, realty gain
Read more: Market LIVE Updates: Sensex, Nifty flat; pharma, auto, realty gain
Pharma Reviews: Understand India's pharma needs but domestic consumption priority: Biden administration
President Joe Biden and his predecessor Donald Trump had invoked the war-time Defence Production Act (DPA) that leaves US companies with no ...
Read more: Understand India's pharma needs but domestic consumption priority: Biden administration
Read more: Understand India's pharma needs but domestic consumption priority: Biden administration
Pharma Reviews: In India, Covid-19 Vaccines Face A More Urgent Problem Than IPR
While Indian pharmaceutical manufacturers have proven to be adept at reverse-engineering small molecule drugs, like the anti-retroviral drugs ...
Read more: In India, Covid-19 Vaccines Face A More Urgent Problem Than IPR
Read more: In India, Covid-19 Vaccines Face A More Urgent Problem Than IPR
Pharma Reviews: 'We understand India's pharma requirements': WH on vax raw material supply
The Biden administration has conveyed to New Delhi that it understands India's pharmaceutical requirements and promised to give the matter a due ...
Read more: 'We understand India's pharma requirements': WH on vax raw material supply
Read more: 'We understand India's pharma requirements': WH on vax raw material supply
Monday, April 19, 2021
Pharma Reviews: Morning News
India's Ambassador to China Vikram Misri says tendency to sweep border ... Prime Minister Narendra Modi has urged the pharma industry to ensure ...
Read more: Morning News
Read more: Morning News
Pharma Reviews: PM appreciated the role of the pharma sector in the fight against the pandemic.
The Prime Minister stated that despite all the challenges, the Indian pharma industry has also registered a growth of 18 per cent in exports last year, ...
Read more: PM appreciated the role of the pharma sector in the fight against the pandemic.
Read more: PM appreciated the role of the pharma sector in the fight against the pandemic.
Pharma Reviews: Stock Market Highlights: Sensex cracks 882 points, Nifty ends below 14400 dragged by banks ...
Stock Market Highlights: Indian equity indices, Sensex and Nifty ended sharply ... Barring Nifty Pharma, all other sectoral indices ended in the red with ...
Read more: Stock Market Highlights: Sensex cracks 882 points, Nifty ends below 14400 dragged by banks ...
Read more: Stock Market Highlights: Sensex cracks 882 points, Nifty ends below 14400 dragged by banks ...
US FDA News: Tenacore LLC Issues Nationwide Recall of Tenacore’s Replacement for the Front Bezel Assembly of the CareFusion Alaris 8100 Infusion Pump Module
On February 24th, 2021, Tenacore LLC initiated a nationwide recall of 2001 Tenacore replacement CareFusion Alaris 8100 bezels due to potentially weakened plastic. A bezel with weakened plastic may, over time, lead to separation of the bezel post (recall issue) as well as other damage to the bezel (e
Read more: Tenacore LLC Issues Nationwide Recall of Tenacore’s Replacement for the Front Bezel Assembly of the CareFusion Alaris 8100 Infusion Pump Module
Read more: Tenacore LLC Issues Nationwide Recall of Tenacore’s Replacement for the Front Bezel Assembly of the CareFusion Alaris 8100 Infusion Pump Module
Pharma Reviews: Johnson & Johnson seeks permission for Ph-3 trial of its single-shot Covid-19 vaccine in India ...
New Delhi: PM Modi today appreciated the role of the pharma sector in the fight against COVID-19. He stated that despite all challenges, the Indian ...
Read more: Johnson & Johnson seeks permission for Ph-3 trial of its single-shot Covid-19 vaccine in India ...
Read more: Johnson & Johnson seeks permission for Ph-3 trial of its single-shot Covid-19 vaccine in India ...
Pharma Reviews: Industry bodies working on a pandemic response: CII, FICCI likely to coordinate
The Centre and state governments have reached out to industry bodies like the Confederation of Indian Industry (CII) and Federation of Indian ...
Read more: Industry bodies working on a pandemic response: CII, FICCI likely to coordinate
Read more: Industry bodies working on a pandemic response: CII, FICCI likely to coordinate
Pharma Reviews: Covid-19: No tolerance for hoarders of essential items during curfew, lockdowns, Centre tells states
6.59 pm: Prime Minister Narendra Modi holds a meeting with executives of the leading pharmaceutical companies of India. Prime Minister Narendra ...
Read more: Covid-19: No tolerance for hoarders of essential items during curfew, lockdowns, Centre tells states
Read more: Covid-19: No tolerance for hoarders of essential items during curfew, lockdowns, Centre tells states
US FDA News: Tenacore Recalls Alaris Pump Bezel Assembly and Alaris Infusion Pumps repaired with Bezel Assembly Due to Possible Cracked or Separated Bezel Repair Posts
The Tenacore Alaris Pump Bezel Assembly services and repairs Alaris infusion pump modules. Over time, the bezel repair posts may crack or separate.
Read more: Tenacore Recalls Alaris Pump Bezel Assembly and Alaris Infusion Pumps repaired with Bezel Assembly Due to Possible Cracked or Separated Bezel Repair Posts
Read more: Tenacore Recalls Alaris Pump Bezel Assembly and Alaris Infusion Pumps repaired with Bezel Assembly Due to Possible Cracked or Separated Bezel Repair Posts
Pharma Reviews: Government limits oxygen supply to industry, diverts it for medical use to battle Covid
Similarly, units in west and south India are catering to states in those regions. A steel company CEO told TOI that there were problems related to ...
Read more: Government limits oxygen supply to industry, diverts it for medical use to battle Covid
Read more: Government limits oxygen supply to industry, diverts it for medical use to battle Covid
Pharma Reviews: Market LIVE Updates: Indices off day's low, but still 2% lower dragged by auto and financials
Market LIVE Updates: Indices off day's low, but still 2% lower dragged by auto and ... improvements / electrical appliances companies, chemical, and pharma. ... We expect the Indian market to trade in a consolidated range between ...
Read more: Market LIVE Updates: Indices off day's low, but still 2% lower dragged by auto and financials
Read more: Market LIVE Updates: Indices off day's low, but still 2% lower dragged by auto and financials
Pharma Reviews: Market LIVE Updates: Sensex tanks over 1200 pts; Nifty near 14.2K; Pharma gains
Benchmark Indian indices were down over 2% on Monday, India's covid cases rose to 12,30,007. Meanwhile, MSCI's broadest index of Asia-Pacific ...
Read more: Market LIVE Updates: Sensex tanks over 1200 pts; Nifty near 14.2K; Pharma gains
Read more: Market LIVE Updates: Sensex tanks over 1200 pts; Nifty near 14.2K; Pharma gains
Pharma Reviews: Expecting big growth in Indian vaccine exports in coming years : Pharmexcil
Though the Covid-19 pandemic has pushed several economies and businesses to the brink, India's pharmaceutical industry stood strong at such a ...
Read more: Expecting big growth in Indian vaccine exports in coming years : Pharmexcil
Read more: Expecting big growth in Indian vaccine exports in coming years : Pharmexcil
Sunday, April 18, 2021
Pharma Reviews: 3rd vax dose likely needed within 12 months: Pfizer CEO
... pharmaceutical companies manufacturing Remdesivir in India have significantly ... Indian pharma exports grow at 18 percent to 24.44 bn in FY 21.
Read more: 3rd vax dose likely needed within 12 months: Pfizer CEO
Read more: 3rd vax dose likely needed within 12 months: Pfizer CEO
Pharma Reviews: Indian pharma exports grow at 18 percent to 24.44 bn in FY 21
North America is the largest exporting region for Indian pharmaceuticals with more than 34 percent share. Country-wise exports to the US, Canada and ...
Read more: Indian pharma exports grow at 18 percent to 24.44 bn in FY 21
Read more: Indian pharma exports grow at 18 percent to 24.44 bn in FY 21
Saturday, April 17, 2021
Pharma Reviews: FY 21: Indian pharma exports grow at 18 percent to 24.44 billion
North America is the largest exporting region for Indian pharmaceuticals with more than 34 percent share. Advertisement. Country-wise exports to the US ...
Read more: FY 21: Indian pharma exports grow at 18 percent to 24.44 billion
Read more: FY 21: Indian pharma exports grow at 18 percent to 24.44 billion
Pharma Reviews: Coronavirus LIVE: Canada reports second clot after AstraZeneca shot
Coronavirus live updates: India's second wave of Covid-19 infections is ... Prime Minister Narendra Modi asked officials to use the pharmaceutical ...
Read more: Coronavirus LIVE: Canada reports second clot after AstraZeneca shot
Read more: Coronavirus LIVE: Canada reports second clot after AstraZeneca shot
Pharma Reviews: Making waves: India heads towards the fourth wave of coronavirus
Russia has contracted five Indian drug companies to manufacture over 850 million doses of Sputnik V vaccines for export. Dr Reddy's Laboratories will ...
Read more: Making waves: India heads towards the fourth wave of coronavirus
Read more: Making waves: India heads towards the fourth wave of coronavirus
Pharma Reviews: Will Sputnik lower $10 per dose global rate in India?
Pharma industry sources indicated that the Indian manufacturers may be able to churn out the vaccine at much lower than $2 per dose. “The cost of ...
Read more: Will Sputnik lower $10 per dose global rate in India?
Read more: Will Sputnik lower $10 per dose global rate in India?
Pharma Reviews: Pharma exports FY 2021: Indian made generics see HUGE demand; grows by 18 percent to ...
Amid Covid 19 pandemic, Indian pharma sector has stood out. It has grown exponentially in Financial Year 2021. Market Experts are also bullish as ...
Read more: Pharma exports FY 2021: Indian made generics see HUGE demand; grows by 18 percent to ...
Read more: Pharma exports FY 2021: Indian made generics see HUGE demand; grows by 18 percent to ...
Pharma Reviews: Coronavirus News Updates Live: Maharashtra reports 67123 fresh cases, highest daily rise so far ...
Mumbai Indians beat Sunrisers Hyderabad by 13 runs ... Need to utilise full potential of India's pharma industry to meet rising demand of various ...
Read more: Coronavirus News Updates Live: Maharashtra reports 67123 fresh cases, highest daily rise so far ...
Read more: Coronavirus News Updates Live: Maharashtra reports 67123 fresh cases, highest daily rise so far ...
Pharma Reviews: Prime Minister reviews Preparedness of Public Health Response to COVID-19
PM spoke about the need to utilize the full potential of India's pharmaceutical industry to meet the rising demand of various medicines. He reviewed ...
Read more: Prime Minister reviews Preparedness of Public Health Response to COVID-19
Read more: Prime Minister reviews Preparedness of Public Health Response to COVID-19
Pharma Reviews: Indian pharma leader and recent UK study hold out a new (sp)ray of hope in the face of acute ...
Now some of the 7 major companies manufacturing Remdesivir have responded by doubling production from the last covid wave. Speaking to a senior ...
Read more: Indian pharma leader and recent UK study hold out a new (sp)ray of hope in the face of acute ...
Read more: Indian pharma leader and recent UK study hold out a new (sp)ray of hope in the face of acute ...
Pharma Reviews: Where India's COVID-19 Vaccination Strategy Went Wrong
The Partnership that Delivered: What India Should Have Done. When the pandemic struck, governments the world over showered pharmaceutical ...
Read more: Where India's COVID-19 Vaccination Strategy Went Wrong
Read more: Where India's COVID-19 Vaccination Strategy Went Wrong
Friday, April 16, 2021
Pharma Reviews: Covid vaccines and lessons: India can benefit from a dose of globalisation
While typical vaccine development cycles last for four or more years, the global pharma industry has developed several safe and effective vaccines in ...
Read more: Covid vaccines and lessons: India can benefit from a dose of globalisation
Read more: Covid vaccines and lessons: India can benefit from a dose of globalisation
Pharma Reviews: Indian pharma exports grow at 18 percent to 24.44 bn in FY 21
AP North America is the largest exporting region for Indian pharmaceuticals with more than 34 per cent share. Pharma exports from India witnessed over ...
Read more: Indian pharma exports grow at 18 percent to 24.44 bn in FY 21
Read more: Indian pharma exports grow at 18 percent to 24.44 bn in FY 21
Pharma Reviews: Indian pharma exports grow at 18 percent to 24.44 billion in FY 21
When the global pharma market is negatively grown by 1-2 per cent in 2020, there is a big surge in demand for Indian made generics owing to its ...
Read more: Indian pharma exports grow at 18 percent to 24.44 billion in FY 21
Read more: Indian pharma exports grow at 18 percent to 24.44 billion in FY 21
Pharma Reviews: ISSAR Pharma announces Out - Licensing of its Peptide-Based NCEs
“We take pride in being India's first ever company to conduct phase-1 clinical trials, and launch the first ever indigenous peptide drug, Melgain in market ...
Read more: ISSAR Pharma announces Out - Licensing of its Peptide-Based NCEs
Read more: ISSAR Pharma announces Out - Licensing of its Peptide-Based NCEs
Pharma Reviews: 5 pharma stocks that could do well going ahead: Daljit Singh Kohli
Cipla, Cadila, Dr Reddy's, Gland Pharma and Aurobindo Pharma are in the preferred list, says Daljeet Singh Kohli · INSIGHTS · PEER COMPANIES.
Read more: 5 pharma stocks that could do well going ahead: Daljit Singh Kohli
Read more: 5 pharma stocks that could do well going ahead: Daljit Singh Kohli
Pharma Reviews: Dr Reddy's working on stability data on 2 to 8 C temperature range for Sputnik V vaccine
The company has received the permission from the Drug Controller General of India (DCGI) to import the Sputnik vaccine into India for restricted use in ...
Read more: Dr Reddy's working on stability data on 2 to 8 C temperature range for Sputnik V vaccine
Read more: Dr Reddy's working on stability data on 2 to 8 C temperature range for Sputnik V vaccine
Pharma Reviews: Covid-19: What you need to know today
India's pharmaceutical industry thrives on generic versions of small molecule drugs; the country's vaccine makers have received a lot of attention over ...
Read more: Covid-19: What you need to know today
Read more: Covid-19: What you need to know today
US FDA News: Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Monoclonal Antibody Bamlanivimab
Today, the FDA revoked the emergency use authorization that allowed for the investigational monoclonal antibody therapy bamlanivimab, when administered alone, to be used for the treatment of mild-to-moderate COVID-19 in adults and certain pediatric patients.
Read more: Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Monoclonal Antibody Bamlanivimab
Read more: Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Monoclonal Antibody Bamlanivimab
US FDA News: Durisan Announces a Voluntary Recall Expansion of its Antimicrobial Hand Sanitizer
Sanit Technologies LLC d/b/a Durisan announces a voluntary recall expansion of its Durisan Antimicrobial Hand Sanitizer, NonAlcohol products in various sizes listed to now include products that have not yet expired. The products are being recalled due to out of specification microbial contamination.
Read more: Durisan Announces a Voluntary Recall Expansion of its Antimicrobial Hand Sanitizer
Read more: Durisan Announces a Voluntary Recall Expansion of its Antimicrobial Hand Sanitizer
Pharma Reviews: Modi govt wants more Covid vaccines, but Moderna is 'not keen' & Pfizer has this 'condition'
New Delhi: In an attempt to bring more Covid-19 vaccines to India to tackle ... These are the legal bonds that protect the company from being sued in ... on board with us and allows our pharma companies to produce the vaccine here.
Read more: Modi govt wants more Covid vaccines, but Moderna is 'not keen' & Pfizer has this 'condition'
Read more: Modi govt wants more Covid vaccines, but Moderna is 'not keen' & Pfizer has this 'condition'
US FDA News: Coronavirus (COVID-19) Update: April 16, 2021
Coronavirus (COVID-19) Update: April 16, 2021
Read more: Coronavirus (COVID-19) Update: April 16, 2021
Read more: Coronavirus (COVID-19) Update: April 16, 2021
Pharma Reviews: Indian vaccine maker Serum Institute appeals to Biden to lift embargo on raw material exports
Respected @POTUS, if we are to truly unite in beating this virus, on behalf of the vaccine industry outside the U.S., I humbly request you to lift the ...
Read more: Indian vaccine maker Serum Institute appeals to Biden to lift embargo on raw material exports
Read more: Indian vaccine maker Serum Institute appeals to Biden to lift embargo on raw material exports
US FDA News: CareFusion 303, Inc. Recalls BD Alaris Pump Module Model 8100 Due to Risk of Stuck or Unresponsive Keys
The Alaris System is a fluid delivery system. The keys may become stuck or unresponsive and may lead to an infusion delay or delay in care.
Read more: CareFusion 303, Inc. Recalls BD Alaris Pump Module Model 8100 Due to Risk of Stuck or Unresponsive Keys
Read more: CareFusion 303, Inc. Recalls BD Alaris Pump Module Model 8100 Due to Risk of Stuck or Unresponsive Keys
US FDA News: FDA Approves First Immunotherapy for Initial Treatment of Gastric Cancer
Today, the FDA approved Opdivo (nivolumab), in combination with certain types of chemotherapy, for the initial treatment of patients with advanced or metastatic gastric cancer, gastroesophageal junction cancer and esophageal adenocarcinoma.
Read more: FDA Approves First Immunotherapy for Initial Treatment of Gastric Cancer
Read more: FDA Approves First Immunotherapy for Initial Treatment of Gastric Cancer
Pharma Reviews: Biggest Covid lesson is to be self-reliant in APIs and minimise dependency on China: Karan ...
“Stimulate R&D in Pharma” – Despite being the largest producer of generic medicines in the world, Indian Pharma companies failed to discover novel ...
Read more: Biggest Covid lesson is to be self-reliant in APIs and minimise dependency on China: Karan ...
Read more: Biggest Covid lesson is to be self-reliant in APIs and minimise dependency on China: Karan ...
Pharma Reviews: We need to leapfrog our thinking on therapeutics that can drastically turn the pandemic table ...
How did it open new opportunities for India's CDMO sector? Most Indian biotech/ pharma companies are catering to the generic drugs market primarily ...
Read more: We need to leapfrog our thinking on therapeutics that can drastically turn the pandemic table ...
Read more: We need to leapfrog our thinking on therapeutics that can drastically turn the pandemic table ...
Thursday, April 15, 2021
Pharma Reviews: West Pharma, Venus Remedies expand partnership to launch NovaGuard SA Pro Safety System in ...
... recently announced its partnership with domestic Indian pharma company Venus Remedies Ltd. whose brand Cloti-Xa has made its introduction in ...
Read more: West Pharma, Venus Remedies expand partnership to launch NovaGuard SA Pro Safety System in ...
Read more: West Pharma, Venus Remedies expand partnership to launch NovaGuard SA Pro Safety System in ...
Pharma Reviews: Covid & the greed of Big Pharma, developed nations
Six months after India and South Africa tabled a proposal in the WTO ... However, a heady mix of avarice of large pharmaceutical companies (the “Big ...
Read more: Covid & the greed of Big Pharma, developed nations
Read more: Covid & the greed of Big Pharma, developed nations
Pharma Reviews: Indian pharma majors urgently need to move up the value chain: Ranjit Shahani, JB Chemicals
Indian pharma majors have to re-evaluate current role within global pharma industry, explore possibilities fr consolidating and strengthening their ...
Read more: Indian pharma majors urgently need to move up the value chain: Ranjit Shahani, JB Chemicals
Read more: Indian pharma majors urgently need to move up the value chain: Ranjit Shahani, JB Chemicals
Pharma Reviews: Ranjit Shahani on India's booming pharma sector | Exclusive
Are branded sales a high growth area for the industry? Ranjit Shahani, Chairman, JB Chemicals and Pharmaceuticals and Former MD, Novartis India ...
Read more: Ranjit Shahani on India's booming pharma sector | Exclusive
Read more: Ranjit Shahani on India's booming pharma sector | Exclusive
Pharma Reviews: As India gears up to emerge as pharmaceutical hub, bet on these 6 stocks
The government's support for the Indian pharma sector has been a major boon. The recent approval for a production-linked incentive (PLI) scheme ...
Read more: As India gears up to emerge as pharmaceutical hub, bet on these 6 stocks
Read more: As India gears up to emerge as pharmaceutical hub, bet on these 6 stocks
Pharma Reviews: Pfizer to pursue bringing Covid-19 vaccine to India after import relaxation
AstraZeneca's drug Tagrisso gets China nod for early lung cancer treatment. China's National Medical Products Administration (NMPA) approved ...
Read more: Pfizer to pursue bringing Covid-19 vaccine to India after import relaxation
Read more: Pfizer to pursue bringing Covid-19 vaccine to India after import relaxation
US FDA News: Medtronic Recalls HeartWare HVAD Battery Cables, Data Cables, Adapter Cables and Controller 2.0 Ports Due to Risk of Damage to Controller Ports
The HeartWare HVAD System pump is used in patients with heart failure. Some pumps may stop because of damaged controller ports
Read more: Medtronic Recalls HeartWare HVAD Battery Cables, Data Cables, Adapter Cables and Controller 2.0 Ports Due to Risk of Damage to Controller Ports
Read more: Medtronic Recalls HeartWare HVAD Battery Cables, Data Cables, Adapter Cables and Controller 2.0 Ports Due to Risk of Damage to Controller Ports
Wednesday, April 14, 2021
Pharma Reviews: China mulls mixing vaccines to improve efficacy of jabs
... none of China's jabs conditionally approved for the market are mRNA vaccines, but products that use the technology include those by US pharma ...
Read more: China mulls mixing vaccines to improve efficacy of jabs
Read more: China mulls mixing vaccines to improve efficacy of jabs
Pharma Reviews: Remdesivir shortage in Nagpur; Gadkari dials Sun Pharma chief
The pharma company chief assured Gadkari of making available 5,000 injections immediately on Saturday and the remaining 5,000 in next two-three ...
Read more: Remdesivir shortage in Nagpur; Gadkari dials Sun Pharma chief
Read more: Remdesivir shortage in Nagpur; Gadkari dials Sun Pharma chief
Pharma Reviews: AstraZeneca's drug Tagrisso gets China nod for early lung cancer treatment
AYUSH Ministry's manufacturing unit IMPCL achieves highest-ever turnover of over Rs 160 crore. Its previous highest turnover was Rs 97 crore in 2019- ...
Read more: AstraZeneca's drug Tagrisso gets China nod for early lung cancer treatment
Read more: AstraZeneca's drug Tagrisso gets China nod for early lung cancer treatment
Pharma Reviews: Factory to the World?
Meanwhile, the second PLI Scheme for pharmaceuticals has come as part of an umbrella programme to make the Indian pharmaceutical industry self- ...
Read more: Factory to the World?
Read more: Factory to the World?
US FDA News: FDA Provides Guidance on Remote Interactive Evaluations for Oversight of Drug Facilities During COVID-19
FDA releases guidance on how remote interactive evaluations will be requested by FDA and conducted for the duration of COVID-19 at drug facilities.
Read more: FDA Provides Guidance on Remote Interactive Evaluations for Oversight of Drug Facilities During COVID-19
Read more: FDA Provides Guidance on Remote Interactive Evaluations for Oversight of Drug Facilities During COVID-19
Pharma Reviews: Pharma industry sees little impact of Maharashtra's curfew-like restrictions on manufacturing ...
The Maharashtra government has allowed pharma manufacturing units to remain ... The offices of pharmaceutical companies needed for management of ... Director, DY-MACH PHARMA and President of Indian Drug Manufacturers ...
Read more: Pharma industry sees little impact of Maharashtra's curfew-like restrictions on manufacturing ...
Read more: Pharma industry sees little impact of Maharashtra's curfew-like restrictions on manufacturing ...
Pharma Reviews: The Rise Of Lifestyle Medicines Sector In India
The Rise Of Lifestyle Medicines Sector In India. The vitamin gummies segment is expected to grow rapidly and close the gap in penetration levels when ...
Read more: The Rise Of Lifestyle Medicines Sector In India
Read more: The Rise Of Lifestyle Medicines Sector In India
Pharma Reviews: AYUSH Ministry's manufacturing unit IMPCL achieves highest-ever turnover of over Rs 160 crore
With its products attracting more buyers, Indian Medicines Pharmaceutical Corporation Limited (IMPCL), the public sector manufacturing unit of the ...
Read more: AYUSH Ministry's manufacturing unit IMPCL achieves highest-ever turnover of over Rs 160 crore
Read more: AYUSH Ministry's manufacturing unit IMPCL achieves highest-ever turnover of over Rs 160 crore
Pharma Reviews: Cipla doubles remdesivir production to meet 'unprecedented' demand
Cipla, one of India's oldest and largest drug manufacturers, has a deal to make and supply U.S.-based Gilead's remdesivir in more than 100 countries.
Read more: Cipla doubles remdesivir production to meet 'unprecedented' demand
Read more: Cipla doubles remdesivir production to meet 'unprecedented' demand
Pharma Reviews: Pfizer seeks Covid vaccine authorization for 12-15 year olds in US
Their request to the Food and Drug Administration in the US comes after ... in the US who the companies said showed "robust anti-body responses."
Read more: Pfizer seeks Covid vaccine authorization for 12-15 year olds in US
Read more: Pfizer seeks Covid vaccine authorization for 12-15 year olds in US
Pharma Reviews: Large Indian IT, pharma companies having presence in US likely to see jump in tax outgo
New Delhi: Large Indian information technology (IT) and pharmaceutical companies that also have operations in the United States stare at a possible ...
Read more: Large Indian IT, pharma companies having presence in US likely to see jump in tax outgo
Read more: Large Indian IT, pharma companies having presence in US likely to see jump in tax outgo
Tuesday, April 13, 2021
Pharma Reviews: HGCO19 vaccine candidate: Gennova starts enrolment for Phase 1/2 human clinical trials
The Indian drug regulator has also granted permission for the restricted ... was a new technology and never used for vaccine manufacturing in India.
Read more: HGCO19 vaccine candidate: Gennova starts enrolment for Phase 1/2 human clinical trials
Read more: HGCO19 vaccine candidate: Gennova starts enrolment for Phase 1/2 human clinical trials
Pharma Reviews: Govt halts exports of Remdesivir: All you need to know about the Covid treatment drug
At present, seven Indian companies are producing Injection Remdesivir under a voluntary licensing agreement with the American pharmaceutical ...
Read more: Govt halts exports of Remdesivir: All you need to know about the Covid treatment drug
Read more: Govt halts exports of Remdesivir: All you need to know about the Covid treatment drug
US FDA News: Coronavirus (COVID-19) Update: April 13, 2021
Coronavirus (COVID-19) Update: April 13, 2021
Read more: Coronavirus (COVID-19) Update: April 13, 2021
Read more: Coronavirus (COVID-19) Update: April 13, 2021
US FDA News: Joint CDC and FDA Statement on Johnson & Johnson COVID-19 Vaccine
Joint CDC and FDA Statement on Johnson & Johnson COVID-19 Vaccine
Read more: Joint CDC and FDA Statement on Johnson & Johnson COVID-19 Vaccine
Read more: Joint CDC and FDA Statement on Johnson & Johnson COVID-19 Vaccine
Pharma Reviews: Coronavirus live updates: Govt fast-tracks emergency approvals for foreign-produced Covid vaccines
Read: WHO urges pause in market sale of captured live wild animals ... by India and would encourage imports, including import of bulk drug material, ...
Read more: Coronavirus live updates: Govt fast-tracks emergency approvals for foreign-produced Covid vaccines
Read more: Coronavirus live updates: Govt fast-tracks emergency approvals for foreign-produced Covid vaccines
Pharma Reviews: Stocks picks with Anil Singhvi: Dr Reddy's, Alkem Laboratories, Torrent Pharma, Ajanta Pharma ...
Currently, 50% vaccine demand is met by India. It is also leading exporter after IT sector. This is anticipated that $55 billion Indian pharmaceutical ...
Read more: Stocks picks with Anil Singhvi: Dr Reddy's, Alkem Laboratories, Torrent Pharma, Ajanta Pharma ...
Read more: Stocks picks with Anil Singhvi: Dr Reddy's, Alkem Laboratories, Torrent Pharma, Ajanta Pharma ...
Pharma Reviews: Indian IVD Manufacturers Played a Big Role in Addressing Covid-19
... or IVD manufacturing landscape in face of Covid-19 pandemic, writes Rajiv Nath, Forum Coordinator, Association of Indian Medical Device Industry ...
Read more: Indian IVD Manufacturers Played a Big Role in Addressing Covid-19
Read more: Indian IVD Manufacturers Played a Big Role in Addressing Covid-19
Monday, April 12, 2021
Pharma Reviews: Indian shares rise after sharp virus-led decline; drug firms jump
... bruising coronavirus-led decline in the last session, as beaten-down banking stocks gained and drug companies climbed due to a vaccine approval.
Read more: Indian shares rise after sharp virus-led decline; drug firms jump
Read more: Indian shares rise after sharp virus-led decline; drug firms jump
Pharma Reviews: SII to start supplying 1st made-in-India pneumococcal conjugate vaccine to Centre from Wednesday
Sitharaman had said that this would avert over 50,000 deaths annually. India's drug regulator had in July last year granted market approval for the ...
Read more: SII to start supplying 1st made-in-India pneumococcal conjugate vaccine to Centre from Wednesday
Read more: SII to start supplying 1st made-in-India pneumococcal conjugate vaccine to Centre from Wednesday
Pharma Reviews: Low production in Jan, Feb led to shortage of Remdesivir
However, pharma industry officials insisted that this is just a temporary ... said Mahesh Doshi, president, Indian Drug Manufacturers' Association.
Read more: Low production in Jan, Feb led to shortage of Remdesivir
Read more: Low production in Jan, Feb led to shortage of Remdesivir
Pharma Reviews: Russia's Sputnik V gets Emergency Use authorisation nod in India
The decision comes after the Drugs Controller General of India (DCGI)'s ... this year, India will be getting vaccines from five additional manufacturers.
Read more: Russia's Sputnik V gets Emergency Use authorisation nod in India
Read more: Russia's Sputnik V gets Emergency Use authorisation nod in India
Pharma Reviews: Pharma industry seeks emergency nod to manufacture Covid drug Remdesivir
The Indian Drug Manufacturers' Association has said in a communication to India's Drugs Controller General “in light of the emergency situation ...
Read more: Pharma industry seeks emergency nod to manufacture Covid drug Remdesivir
Read more: Pharma industry seeks emergency nod to manufacture Covid drug Remdesivir
Pharma Reviews: “We anticipate demand for pharmaceutical packaging products to increase in the foreseeable future”
Mehul Chawla, Regional Business Leader – Life Sciences, Protective, Fluorine Products, Honeywell Advanced Materials, India shares more details ...
Read more: “We anticipate demand for pharmaceutical packaging products to increase in the foreseeable future”
Read more: “We anticipate demand for pharmaceutical packaging products to increase in the foreseeable future”
US FDA News: Smisson-Cartledge Biomedical, LLC Recalls ThermaCor 1200 Disposable Sets for Risk of Patient Contact to Aluminum
The ThermaCor 1200 Disposable Sets are part of a portable fluid delivery device system and are being recalled for patient aluminum contact risk.
Read more: Smisson-Cartledge Biomedical, LLC Recalls ThermaCor 1200 Disposable Sets for Risk of Patient Contact to Aluminum
Read more: Smisson-Cartledge Biomedical, LLC Recalls ThermaCor 1200 Disposable Sets for Risk of Patient Contact to Aluminum
US FDA News: Medtronic Recalls Evera, Viva, Brava, Claria, Amplia, Compia, and Visia Implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapy (CRT-Ds) Due to Risk of Shortened Battery Life
Medtronic’s Evera, Viva, Brava, Claria, Amplia, Compia, and Visia ICDs and CRT-Ds correct heart arrhythmia. Some devices may have shortened battery life.
Read more: Medtronic Recalls Evera, Viva, Brava, Claria, Amplia, Compia, and Visia Implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapy (CRT-Ds) Due to Risk of Shortened Battery Life
Read more: Medtronic Recalls Evera, Viva, Brava, Claria, Amplia, Compia, and Visia Implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapy (CRT-Ds) Due to Risk of Shortened Battery Life
Pharma Reviews: Pharma Manufacturing is Focusing on Automation
Q What are the main dynamics you are witnessing in the pharma manufacturing sector in India for the past one year? What about the country's ...
Read more: Pharma Manufacturing is Focusing on Automation
Read more: Pharma Manufacturing is Focusing on Automation
Pharma Reviews: Stock Market Live: Sensex at day's low, Nifty slips below 14300 on lockdown concerns; financials ...
Stock Market Live: Indian equity indices, Sensex and Nifty fell sharply over 3.5 ... “Markets will have to reassess whether economically sensitive sectors, ... Active Pharma will merge with it creating a pure-play active pharmaceutical ...
Read more: Stock Market Live: Sensex at day's low, Nifty slips below 14300 on lockdown concerns; financials ...
Read more: Stock Market Live: Sensex at day's low, Nifty slips below 14300 on lockdown concerns; financials ...
Sunday, April 11, 2021
Pharma Reviews: India to have 5 more vaccines by Oct, Sputnik nod likely in 10 days: Report
Russian Direct Investment Fund (RDIF) has tied up with a host of Indian pharmaceutical players such as Hyderabad based Dr Reddy's Laboratories, ...
Read more: India to have 5 more vaccines by Oct, Sputnik nod likely in 10 days: Report
Read more: India to have 5 more vaccines by Oct, Sputnik nod likely in 10 days: Report
Subscribe to:
Comments (Atom)